Literature DB >> 18939707

IFHNOS Global Continuing Education Program. Current concepts in head & neck surgery and oncology 2008.

.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18939707      PMCID： PMC2667237     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN： 0392-100X            Impact factor:   2.124


× No keyword cloud information.
  35 in total

1.  Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation.

Authors:  M N Saleh; K P Raisch; M A Stackhouse; W E Grizzle; J A Bonner; M S Mayo; H G Kim; R F Meredith; R H Wheeler; D J Buchsbaum
Journal:  Cancer Biother Radiopharm       Date:  1999-12       Impact factor: 3.099

2.  Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.

Authors:  T Akimoto; N R Hunter; L Buchmiller; K Mason; K K Ang; L Milas
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

3.  Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.

Authors:  C M Balch; S J Soong; T Smith; M I Ross; M M Urist; C P Karakousis; W J Temple; M C Mihm; R L Barnhill; W R Jewell; H J Wanebo; R Desmond
Journal:  Ann Surg Oncol       Date:  2001-03       Impact factor: 5.344

4.  C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

Authors:  S Nasu; K K Ang; Z Fan; L Milas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

5.  Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland.

Authors:  C J O'Brien; E B McNeil; J D McMahon; I Pathak; C S Lauer
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

Review 6.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors:  Jean Bourhis; Jens Overgaard; Hélène Audry; Kian K Ang; Michele Saunders; Jacques Bernier; Jean-Claude Horiot; Aurélie Le Maître; Thomas F Pajak; Michael G Poulsen; Brian O'Sullivan; Werner Dobrowsky; Andrzej Hliniak; Krzysztof Skladowski; John H Hay; Luiz H J Pinto; Carlo Fallai; Karen K Fu; Richard Sylvester; Jean-Pierre Pignon
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

7.  Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes.

Authors:  Jennifer L Andruchow; Michael J Veness; Gary J Morgan; Kan Gao; Anthony Clifford; Kerwin F Shannon; Michael Poulsen; Lizbeth Kenny; Carsten E Palme; Patrick Gullane; Christopher Morris; William M Mendenhall; Kepal N Patel; Jatin P Shah; Christopher J O'Brien
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

8.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Authors:  James A Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K Kian Ang
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

9.  The epidermal growth factor receptor mediates radioresistance.

Authors:  Ke Liang; K Kian Ang; Luka Milas; Nancy Hunter; Zhen Fan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-09-01       Impact factor: 7.038

Review 10.  Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.

Authors:  S M Huang; P M Harari
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.651
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.